Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 May;6(5):101358.
doi: 10.1016/j.ajogmf.2024.101358. Epub 2024 Mar 27.

Racial disparity in efficacy of docosahexaenoic acid supplementation for prevention of preterm birth: secondary analysis from a randomized, double-blind trial

Emily A DeFranco  1 , Christina J Valentine  2 , Susan E Carlson  3 , Scott A Sands  3 , Byron J Gajewski  4
Affiliations
Randomized Controlled Trial

Racial disparity in efficacy of docosahexaenoic acid supplementation for prevention of preterm birth: secondary analysis from a randomized, double-blind trial

Emily A DeFranco et al. Am J Obstet Gynecol MFM. 2024 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclaimer:

SEC, BJG and CJV were PIs and EAD a site-PI of the multisite trial conducted under R01HD083292; SEC has received honorariums for presentations about DHA in infancy and pregnancy; CJV was an employee of RB Nutrition, which produces infant formulas and supplements with DHA at the time the study was conducted, however, RB was not involved in the study execution or analysis. CJV conducted this study through her role as an Adjunct Professor at The University of Cincinnati. The other authors have no competing interests.

Figures

Figure.
Figure.
High baseline DHA Level and Randomization to High dose DHA Supplement Decreased the Racial Disparity in Preterm and Early Preterm Birth
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018;11:CD003402. - PMC - PubMed
    1. Carlson SE, Gajewski BJ, Valentine CJ, Kerling EH, Weiner CP, Cackovic M, et al. Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial. EClinicalMedicine. 2021;36:100905. - PMC - PubMed
    1. Carlson SE, Gajewski BJ, Valentine CJ, Rogers LK, Weiner CP, DeFranco EA, et al. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol. BMC Pregnancy Childbirth. 2017;17(1):62. - PMC - PubMed
    1. Simmonds LA, Sullivan TR, Skubisz M, Middleton PF, Best KP, Yelland LN, et al. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG 2020;127(8):975–81. - PubMed
    1. Carlson SE, Gajewski BJ, Valentine CJ, Sands SA, Brown AR, Kerling EH, et al. Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancy. Clinical Nutrition. 2023; [In press]. - PMC - PubMed

Publication types

Substances

LinkOut - more resources